Roivant Sciences Ltd (ROIV)
11.16
-0.22
(-1.93%)
USD |
NASDAQ |
May 08, 15:46
Roivant Sciences Price to Book Value: 1.477 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 1.506 |
| May 06, 2024 | 1.535 |
| May 03, 2024 | 1.507 |
| May 02, 2024 | 1.487 |
| May 01, 2024 | 1.483 |
| April 30, 2024 | 1.442 |
| April 29, 2024 | 1.473 |
| April 26, 2024 | 1.460 |
| April 25, 2024 | 1.440 |
| April 24, 2024 | 1.442 |
| April 23, 2024 | 1.448 |
| April 22, 2024 | 1.403 |
| April 19, 2024 | 1.384 |
| April 18, 2024 | 1.371 |
| April 17, 2024 | 1.382 |
| April 16, 2024 | 1.417 |
| April 15, 2024 | 1.434 |
| April 12, 2024 | 1.448 |
| April 11, 2024 | 1.478 |
| April 10, 2024 | 1.482 |
| April 09, 2024 | 1.510 |
| April 08, 2024 | 1.539 |
| April 05, 2024 | 1.554 |
| April 04, 2024 | 1.523 |
| April 03, 2024 | 1.523 |
| Date | Value |
|---|---|
| April 02, 2024 | 1.445 |
| April 01, 2024 | 1.380 |
| March 28, 2024 | 1.395 |
| March 27, 2024 | 1.434 |
| March 26, 2024 | 1.334 |
| March 25, 2024 | 1.317 |
| March 22, 2024 | 1.343 |
| March 21, 2024 | 1.358 |
| March 20, 2024 | 1.325 |
| March 19, 2024 | 1.314 |
| March 18, 2024 | 1.306 |
| March 15, 2024 | 1.342 |
| March 14, 2024 | 1.354 |
| March 13, 2024 | 1.405 |
| March 12, 2024 | 1.362 |
| March 11, 2024 | 1.382 |
| March 08, 2024 | 1.413 |
| March 07, 2024 | 1.476 |
| March 06, 2024 | 1.531 |
| March 05, 2024 | 1.535 |
| March 04, 2024 | 1.519 |
| March 01, 2024 | 1.558 |
| February 29, 2024 | 1.514 |
| February 28, 2024 | 1.550 |
| February 27, 2024 | 1.562 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.179
Minimum
May 12 2022
11.29
Maximum
Sep 27 2023
4.271
Average
2.877
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 6.934 |
| Biodexa Pharmaceuticals Plc | 0.7432 |
| Verona Pharma PLC | 4.843 |
| NuCana PLC | 0.4036 |
| Autolus Therapeutics PLC | 9.757 |
Price to Book Value Related Metrics
| PE Ratio | 2.146 |
| PS Ratio | 70.54 |
| Price | 11.16 |
| Earnings Yield | 46.59% |
| Market Cap | 8.993B |